000153 丰原药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.4558.8058.9007.7957.580
总资产报酬率 ROA (%)1.0343.5953.6223.1962.883
投入资产回报率 ROIC (%)1.5235.2655.2424.6514.207

边际利润分析
销售毛利率 (%)25.70225.70828.22829.74834.663
营业利润率 (%)5.9414.9885.0474.2903.931
息税前利润/营业总收入 (%)6.5465.6295.7995.4285.383
净利润/营业总收入 (%)4.1373.6793.7703.2273.074

收益指标分析
经营活动净收益/利润总额(%)92.74782.30276.54478.09662.449
价值变动净收益/利润总额(%)-15.639-0.7357.3276.08712.693
营业外收支净额/利润总额(%)0.3050.7630.0961.9755.472

偿债能力分析
流动比率 (X)0.9430.9450.8860.9640.842
速动比率 (X)0.6900.6600.5880.6270.586
资产负债率 (%)58.09756.30460.73756.36160.179
带息债务/全部投入资本 (%)30.12527.44836.83929.401--
股东权益/带息债务 (%)202.672229.778153.594208.781150.114
股东权益/负债合计 (%)70.99876.41763.67776.13664.595
利息保障倍数 (X)11.1549.3347.7655.1634.395

营运能力分析
应收账款周转天数 (天)72.97062.47260.87266.0340.000
存货周转天数 (天)61.76072.12584.81082.9250.000